AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

LEUPROLIDE ACETATE

14 registrations across 6 African markets— 14 active

Markets with LEUPROLIDE ACETATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
LUPRODEX 11.25MG (DEPOT)
POWDER/INJECTABLE; INJECTION
🇿🇼ZimbabweBHARAT SERUMS AND VACCINES LIMITEDactiveFeb 2031
LUPRODEX 3.75MG
POWDER/INJECTABLE; INJECTION
🇿🇼ZimbabweBHARAT SERUMS AND VACCINES LIMITEDactiveFeb 2031
Luprodex 3.75 Injection
lyophilized powder
🇿🇲ZambiaBharat Serums and Vaccines LimitedactiveMar 2030
PREULAD🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveOct 2028
GENPROLEX🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveOct 2028
PRINOLID 7,5🇿🇦South AfricaEurolab (Pty) LtdactiveJan 2028
PRINOLID 11,25🇿🇦South AfricaEurolab (Pty) LtdactiveJan 2028
PRINOLID 3,75🇿🇦South AfricaEurolab (Pty) LtdactiveJan 2028
LEUPROLIDE ACETATE
PARENTERAL ORDINARY S C VIALS
🇺🇬UgandaBHARAT SERUMS AND VACCINES LTDactive
LEUPROLIDE ACETATE
PARENTERAL ORDINARY S C VIALS
🇺🇬UgandaBHARAT SERUMS AND VACCINES LTDactive
Luprodex
Freeze dried powder for injection
🇹🇿TanzaniaBharat Serums and Vaccines Limitedactive
LEUPROLIDE ACETATE
PARENTERAL ORDINARY S C VIALS
🇺🇬UgandaBHARAT SERUMS AND VACCINES LTDactive
LEUPROLIDE ACETATE
PARENTERAL ORDINARY S C VIALS
🇺🇬UgandaBHARAT SERUMS AND VACCINES LTDactive
LUPRODEX 3,75MG POUDRE LYOPHILISEE POUR SOLUTION INJECTABLE SC/I.M BOITE DE 1🇨🇮Côte d'IvoireBHARAT SERUMS & VACCINES LIMITEDactive

LEUPROLIDE ACETATE in Africa — Regulatory Overview

LEUPROLIDE ACETATE is registered across 6 African markets with 14 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Uganda, Zimbabwe, Côte d'Ivoire and 2 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 14 registrations, 14 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.